Relmada Therapeuticsincis A Clinical Stage Biotechnology Company Based In Coral Gablesfloridafocused On Developing Treatments For Central Nervous Systemcnsdisordersfounded In 2004The Company Employs 17 Professionals And Is Publicly Traded On Nasdaq Under The Ticker Rlmdrelmada Leverages The Expertise Of Industry Veterans From Leading Biopharmaceutical Firms To Advance Its Innovative Therapies The Company S Pipeline Includes Several Promising Candidatesrel 1017Esmethadoneis Being Investigated As An Adjunctive Treatment For Major Depressive Disorderndv 01 Is A Controlled Release Formulation Currently In Phase 2 Trials For Non Muscle Invasive Bladder Cancersepranolone Is A Neurosteroid Under Study For Various Neurological Conditionsincluding Prader Willi Syndrome And Tourette Syndromerelmada Is Committed To Progressing Its Pipeline And Expanding Its Therapeutic Portfolio Through Strategic Acquisitions And Collaborations With Top Academic And Medical Institutions
